LeMaitre Vascular Inc
LeMaitre Vascular Inc maintains a strong liquidity position with a current ratio of 12.89, indicating a robust ability to meet short-term obligations. The company's liquidity_fpt score is high, supported by a cash and equivalents balance of $28.24 million. However, the company's net cash position is negative after subtracting total debt, which may pose a liquidity risk in the medium term. The company's profitability is above the industry median, with a return on equity (ROE) of 14.67% and a return on assets (ROA) of 9.38%. These metrics suggest that LeMaitre Vascular Inc is effectively utilizing its equity and assets to generate returns. The gross profit margin of 71.5% is also strong, indicating efficient cost management and pricing power. Geographically, LeMaitre Vascular Inc's revenue is concentrated in the United States, with a significant portion of its sales derived from domestic operations. The company's exposure to international markets is limited, which may reduce diversification benefits but also insulate it from foreign exchange and geopolitical risks. Looking ahead, the company is projected to experience moderate revenue growth. The current fiscal year is expected to see a 4.5% increase in revenue, with a further 3.2% growth anticipated in the next fiscal year. This growth trajectory is supported by a stable operating cash flow of $81.25 million and a free cash flow of $43.26 million, which provide flexibility for reinvestment and shareholder returns. The company faces several risk factors, including the potential for dilution, although the risk is currently assessed as low. The risk assessment indicates a medium liquidity risk, primarily due to the negative net cash position after accounting for total debt. Additionally, the company's reliance on a single product line and the competitive nature of the medical device industry pose ongoing challenges. Recent events, including the filing of the 10-K for the fiscal year ended December 31, 2023, highlight the company's financial health and strategic direction. The 10-K filing provides detailed insights into the company's operations, financial condition, and risk factors, which are essential for investors to understand the company's performance and future prospects.
Business. LeMaitre Vascular Inc designs, develops, and markets vascular surgical products used in the treatment of peripheral vascular disease.
Classification. LeMaitre Vascular Inc is classified in the Healthcare sector under the Advanced Medical Equipment & Technology industry with a confidence level of 0.92.
- LeMaitre Vascular Inc has a strong liquidity position with a current ratio of 12.89.
- The company's profitability is above the industry median, with a ROE of 14.67% and a ROA of 9.38%.
- Revenue is primarily concentrated in the United States, reducing diversification benefits.
- The company is projected to experience moderate revenue growth in the next two fiscal years.
- The risk of dilution is currently assessed as low, but the company faces medium liquidity risk.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.